Drug Discovery World

MARCH 29, 2023

On January 31 2023, an internally circulated version of the European Commission’s overhaul of the EU’s pharma legislation was leaked, and published by Politico 1. The draft also proposes a voucher system for antibiotic development, in which vouchers will grant one extra year of RDP, transferable to other drugs or sellable.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Pharma Companies 52

Pharma Companies Clinical Trials Trials Clinical Research 52

Drug Discovery World

OCTOBER 16, 2023

From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC). At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Drug Discovery World

DECEMBER 14, 2023

With leading academic institutions and significant recent investment, Glasgow is shaping up to be an important centre for drug discovery and development in the UK. In early December 2023, the University of Glasgow announced plans to construct a new Health Innovation Hub in Govan in Glasgow.

Drugs 189

Drugs Science Research Laboratories 189

Drug Discovery World

JANUARY 21, 2024

Bushell will discuss the history and technological underpinnings of induced proximity, the lessons learned from the PROTAC (proteolysis-targeting chimeric) example, and how technology can create enhancement-targeting chimeric, or ENTAC, drugs and fully realise the potential of targeted protein enhancement. Is pharma’s commercial model dying?

Vaccine 130

Vaccine Computational Chemistry Animal Testing Engineering 130

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). By geographical region, the global CRO services market in 2023 was dominated by North America. billion in 2023 attributable to its laboratory products and biopharma services segment (53.8% of total revenue).

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

FEBRUARY 10, 2023

A good part of half of those are within pharma. The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.”

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Discovery World

MAY 7, 2024

Whilst initiatives such as the AMR Action Fund, which aims to develop two–four new antibiotics by 2030, has received investment from the likes of Novartis, Takeda, Pfizer, Roche, and others, there is still a lack of R&D efforts by the larger companies, meaning that the task is being left to SMEs who face risks relating to cost and expansion.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

Drug Discovery World

AUGUST 10, 2023

In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months – and explore some of the most prominent themes and priorities seen throughout 2023.

Pharmaceutical Companies 245

Pharmaceutical Companies Production Science Pharma Companies 245

Metabolite Tales Blog

DECEMBER 19, 2023

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group A Metabolite Bioanalysis Working Group comprised of experts from 14 different pharma companies have proposed recommendations around best practice in metabolite bioanalysis during drug development.

Pharma Companies 52

Pharma Companies Compliance Drug Development Trials 52

Drug Discovery World

JULY 19, 2023

The tide has been turning in the worlds of diagnostics and drug development. In the US, the Biden administration has made advancing precision medicine, multi-omics, cell therapies and artificial intelligence-driven drug development all a priority in its 20-year plan.

Science 130

Science Bioinformatics Pharma Companies Disease 130

Elrig

APRIL 29, 2024

Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader. big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups. There, I supported AI-enabled DD efforts in their small molecule portfolio.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Codon

FEBRUARY 13, 2024

By 2004, over a dozen companies were working on developing phage products and therapies, in locations ranging from Baltimore to Bangalore, where ten years previously, there had been none. Fast forward to 2023. At least a million people die from drug-resistant bacterial infections every year.

Therapies 138

Therapies DNA Virus Clinical Trials 138